ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Roche's first-line Tecentriq combo scores accelerated FDA review
pharmafile
December 07, 2018Roche’s immunotherapy Tecentriq has secured Priority Review from the FDA, the company has announced, in combination with carboplatin and etoposide (chemotherapy) for the first-line treatment of extensive-stage small cell lung cancer (ESCLC). -
FDA accepts Roche’s BLA for emicizumab to treat Haemophilia A
expressbpd
August 28, 2017The US Food and Drug Administration (FDA) has accepted Roche’s biologics licence application (BLA) and granted priority review for emicizumab prophylaxis (preventative) to treat patients with haemophilia A with factor VIII inhibitors.
Pharma Sources Insight January 2025
